The present invention relates to compounds of formula (I):
##STR1##
useful in treating Alzheimer's disease and other similar diseases. These compounds
include inhibitors of the beta-secretase enzyme that are useful in the treatment
of Alzheimer's disease and other diseases characterized by deposition of A beta
peptide in a mammal. The compounds of the invention are useful in pharmaceutical
compositions and methods of treatment to reduce A beta peptide formation.
